We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Agilon Health (AGL - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Agilon Health is a member of the Medical sector. This group includes 1012 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Agilon Health is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AGL's full-year earnings has moved 14.5% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that AGL has returned about 56.8% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 6.7% on average. This means that Agilon Health is outperforming the sector as a whole this year.
Akero Therapeutics, Inc. (AKRO - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 63.7%.
The consensus estimate for Akero Therapeutics, Inc.'s current year EPS has increased 6.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Agilon Health belongs to the Medical Services industry, a group that includes 59 individual stocks and currently sits at #84 in the Zacks Industry Rank. This group has gained an average of 2.5% so far this year, so AGL is performing better in this area.
On the other hand, Akero Therapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry. This 510-stock industry is currently ranked #71. The industry has moved +5.7% year to date.
Agilon Health and Akero Therapeutics, Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Agilon Health (AGL - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Agilon Health is a member of the Medical sector. This group includes 1012 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Agilon Health is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AGL's full-year earnings has moved 14.5% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that AGL has returned about 56.8% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 6.7% on average. This means that Agilon Health is outperforming the sector as a whole this year.
Akero Therapeutics, Inc. (AKRO - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 63.7%.
The consensus estimate for Akero Therapeutics, Inc.'s current year EPS has increased 6.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Agilon Health belongs to the Medical Services industry, a group that includes 59 individual stocks and currently sits at #84 in the Zacks Industry Rank. This group has gained an average of 2.5% so far this year, so AGL is performing better in this area.
On the other hand, Akero Therapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry. This 510-stock industry is currently ranked #71. The industry has moved +5.7% year to date.
Agilon Health and Akero Therapeutics, Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.